Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL) reported Q4 EPS of $1.83, $0.11 better than the analyst estimate of ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE